Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “TOXOPLASMOSIS”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 757 records · Page 42Linked to original sources

[Toxoplasmosis in goats in the Netherlands: a pilot study].

A pilot-study was carried out on ten Dutch goat farms to see whether there is a relationship between farm management factors and the occurrence of toxoplasmosis. Questionnaires were used to collect information about farm management factors and blood samples were taken to determine the prevalence of toxoplasmosis on these farms. The mean prevalence was 47% (range 5-90%). The presence of kittens on a farm was a risk factor for a higher prevalence of toxoplasmosis.

Animal Husbandry↗

Toxoplasmosis as a public health hazard.

Recent advances in the epidemiology and life cycle of toxoplasmosis are reviewed. Cats play a key role. Toxoplasma has a coccidian-type entero-epithelial cycle with oocyst prodlction in the feline host. An extra-intestinal cycle occurs in both feline and non-feline hosts. The worldwide distribution and the public health significance of toxoplasmosis as a zoonosis is discussed, with particular reference to available data regarding Southern Africa.

Animals↗

Toxoplasmosis infection associated with raw goat's milk.

In October 1978, a large family cluster of acute toxoplasmosis was identified in northern California. Indirect fluorescent IgM antibody tests showed that ten of 24 members of an extended family had serological evidence of acute Toxoplasma infection. The index case had retinochoroiditis; the other nine persons had asymptomatic infections. All ten seropositive persons had recently consumed raw goat's milk from the family herd as compared with no consumption of raw milk by the 14 persons with negative results. No dietary item or other risk factors were as strongly associated with positive serological test results as raw milk consumption. Although ingestion of soil-transmitted oocysts could not be ruled out unequivocally as the source of infection, the data suggest that drinking raw milk from infected goats might be another possible vehicle for the transmission of toxoplasmosis.

Adolescent↗

Toxoplasmosis.

Toxoplasmosis infection occurs worldwide wherever cats are present. However, toxoplasmosis, the disease, is relatively rare. In this article, the author examines the cycle of transmission, addresses the problem of congenital transmission, discusses the symptomatology and pathogenesis, diagnosis and treatment, and prevention and control of the disease.

Adolescent↗

Molecular diagnosis of toxoplasmosis.

Toxoplasmosis is an anthropozoonotic disease endemic world-wide, caused by the apicomplexan Toxoplasma gondii. Although the course of infection is generally benign, it can cause significant morbidity and mortality in the developing fetus and in immunocompromised individuals. Biological diagnosis classically relies upon serology and direct detection of the parasite by inoculation to laboratory animals. In the past decade, the use of the polymerase chain reaction (PCR) has made a significant improvement in both the prenatal diagnosis of congenital toxoplasmosis and the detection of acute disease in the immunocompromised patient. Nevertheless, like many 'in-house' PCR assays, the PCR-Toxoplasma suffers from lack of standardization and variable performance according to the laboratory. A wide variety of primers has been used in different assays, but few comparative tests have been performed. Moreover, in contrast to other parasitic diseases, PCR-Toxoplasma has not yet attained a sufficient level of sensitivity, regardless of the clinical condition considered. These drawbacks are discussed, together with the undoubted gain that PCR has brought to this difficult diagnosis.

Humans↗

Toxoplasmosis: comparative species susceptibility and host immune response.

The protozoan parasite Toxoplasma gondii is capable of infecting all warm blooded animals; however, the consequences of infection are very variable between different species of animal. Marsupials and New World monkeys, which have evolved largely separately from the cat, the definitive host of the parasite, are among the most vulnerable species where infection with T. gondii can prove fatal. In more resistant species such as humans and sheep, infection is generally unapparent, provoking only mild symptoms; thereafter the host remains infected for life. However, when the immune system is compromised, such as in the immunologically immature fetus, infection with the parasite can have very serious consequences. Much of the work examining host immune responses has been done using experimentally infected mice. While there are many advantages in using this experimental model, care should be taken in extrapolating results from mice to other species. Mice are extremely vulnerable to the consequences of infection with T. gondii., and their use to further our understanding of congenital toxoplasmosis may not be ideal, as fetal infection can occur in successive pregnancies. This is not the case in rats or sheep; they are more resistant to the disease and therefore may provide a more relevant model for human congenital toxoplasmosis. Studies of host immune responses have emphasised the importance of the cytokine interferon gamma (IFN gamma) in resistance to T. gondii. The efficiency of induction of this cytokine may be critical for determining the outcome of the host-parasite relationship.

Animals↗

Acquired toxoplasmosis.

An outbreak of systemic toxoplasmosis occurred in October 1977 in Atlanta, Georgia. Thirty-seven people became ill and/or had serologic evidence of acute infection. Epidemiologic study by the Center for Disease Control (CDC) suggested that toxoplasma oocysts from infected cats in a riding stable were the source of infection. Aerolization of oocysts or hand-to-mouth contact were the presumptive means of transmission. All patients were examined and followed for over a year, without evidence of toxoplasma retinochoroiditis. In a four-year follow-up study, only one patient had shown evidence of ocular disease. This suggests that at least some sporadic cases are due to acquired toxoplasmosis.

Animals↗

Cotrimoxazole for prenatal treatment of congenital toxoplasmosis?

Congenital toxoplasmosis is still one of the most frequent causes of fetal death. Despite a significant improvement in diagnosis, particularly in utero diagnosis, maternal treatment is only partially effective in preventing transmission to the fetus and treating fetal infection. Maternal treatment is based on drugs developed 50 years ago, which may have limited efficacy (spiramycin) or serious side-effects (pyrimethamine). Data on the use of cotrimoxazole in mouse models of toxoplasmosis and for preventing toxoplasmic encephalitis in patients suffering from AIDS have led Francis Derouin and colleagues to consider the potential of cotrimoxazole for prenatal prevention and treatment of toxoplasmic fetal death.

Animals↗

Toxoplasmosis, an overview with emphasis on ocular involvement.

Toxoplasmosis is a common parasitic zoonosis and an important cause of abortions, mental retardation, encephalitis, blindness, and death worldwide. Although a large body of literature has emerged on the subject in the past decades, many questions about the pathogenesis and treatment of the disease remain unanswered. This review aims to provide an overview of the current insights regarding the causative parasite and the mechanisms leading to symptomatic infection with emphasis on ocular toxoplasmosis.

Acute Disease↗

Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial.

Between December 1981 and May 1991, 44 infants and children with congenital toxoplasmosis were referred to our study group. A uniform approach to evaluation and therapy was developed and is described herein along with the clinical characteristics of these infants and children. In addition, case histories that illustrate especially important clinical features or previously undescribed findings are presented. Factors that contributed to the more severe disabilities included delayed diagnosis and initiation of therapy; prolonged, concomitant neonatal hypoxia and hypoglycemia; profound visual impairment; and prolonged, uncorrected increased intracranial pressure with hydrocephalus and compression of the brain. Years after therapy was discontinued, three children developed new retinal lesions (without loss of visual acuity when therapy for Toxoplasma gondii was initiated promptly), and three children experienced a new onset of afebrile seizures. Most remarkable were the normal developmental, neurological, and ophthalmologic findings at the early follow-up evaluations of many--but not all--of the treated children despite severe manifestations, such as substantial systemic disease, hydrocephalus, microcephalus, multiple intracranial calcifications, and extensive macular destruction detected at birth. These favorable outcomes contrast markedly with outcomes reported previously for children with congenital toxoplasmosis who were untreated or treated for only 1 month.

Animals↗

Toxopain-1 is critical for infection in a novel chicken embryo model of congenital toxoplasmosis.

We tested the hypothesis that cathepsins and specifically toxopain-1, a cathepsin B, play a critical role in the pathogenesis of toxoplasmosis. We found that inhibiting the expression of toxopain-1-specific mRNA and protein by >60% significantly decreased the capacity of the parasites to multiply and invade in vitro. To relate these in vitro results to the role of toxopain-1 in pathogenesis in vivo, we developed a novel chicken embryo model of congenital toxoplasmosis. Inhibiting either toxopain-1 expression or specific cysteine proteinase activity significantly reduced congenital infection of chicken embryos, as determined by histopathology and by the number of parasites quantified by real-time PCR. Our new model provides key in vivo validation for the hypothesis that toxopain-1 is a potential drug target in Toxoplasma gondii and also provides a new animal model for rapid, inexpensive screening of antiparasitic compounds.

Animals↗

[Method of polymerase chain reaction in toxoplasmosis diagnosis].

Since introduction of polymerase chain reaction for the detection of DNA Toxoplasma gondii 398 biological samples from 301 patients were examined from 2000 to 2003. Positive finding of toxoplasmosis DNA we noted in 23 cases. Polymerase chain reaction enables exact and fast diagnosis of the actual parasitemia Toxoplasma gondii, which is important especially in the pregnant patients, new-born with suspicion on congenital toxoplasmosis and in the patients with immunosupression.

Animals↗

Toxoplasmosis: a review.

Toxoplasma gondii, the causative agent of toxoplasmosis, is one of the commonest protozoan parasites of man. It is found world-wide. Although the infection is common as indicated by a high prevalence of toxoplasma antibody among almost all human populations, the clinical disease is observed in only a small proportion of those infected. The most serious complications of infection are seen in infants of women who acquire the infection during pregnancy and in immuno-compromised patients. Clinical manifestations of the disease in the normal host, in compromised hosts including acquired immune deficiency syndrome (AIDS), in pregnancy, eye infection and the relationship of toxoplasmosis to abortion are discussed in detail. In addition, various serologic tests used in the diagnosis, their interpretation, and treatment regimens for various categories of patients are reviewed. Finally, the preventive measures and the serologic screening programs for pregnant women are discussed.

Acquired Immunodeficiency Syndrome↗

Some aspects of the pathogenesis and comparative pathology of toxoplasmosis.

Some aspects of the pathogenesis and comparative pathology of toxoplasmosis are described. The general pattern of infection, with or without necrosis, and tissue cyst formation as it occurs in all species is dealt with. The wide pathological manifestations of toxoplasmosis as seen in sheep, cattle, pigs, horses, dogs, cats, chinchillas and man are reviewed.

Animals↗

[Application from chemiluminescence to serological diagnosis of human toxoplasmosis].

Diagnostic Products Corporation has chosen chemiluminescent for the new kit of quantitative measurement of IgG and qualitative detection of IgM antibodies to Toxoplasma gondii, 878 human sera of principal diagnosis situations were tested, and the results obtained with the IMMULITE Toxoplasmosis kit were compared with those of the Parasitology and Mycology Laboratory of the University of Lille. Chemiluminescent allows a sensitive and specific determination of immunity. In the same ways, this method is able to detect earlier specific IgM and IgG during seroconversion. The kit of quantitative measurement of IgG and qualitative detection of IgM is reproducible and sensitive; this confirms the interest for the pediatric diagnosis of congenital toxoplasmosis.

Aged↗

Toxoplasmosis.

Recent advances in understanding toxoplasmosis have been made in the areas of the basic biology of the parasite and the host-parasite interaction, especially the cellular immune response. There is new insight into the biology of the cyst stage that is responsible for meat-associated transmission of infection and for the reactivation of disease in chronically infected humans. Fewer recent advances have been made in clinical diagnosis and treatment of toxoplasmosis. The fascinating revelation that Toxoplasma gondii contains an organelle--now known as the apicoplast--that derives from an algal endosymbiont, has opened many avenues of basic investigation. An understanding of the fundamental biology of T. gondii promises future progress in prevention or treatment of toxoplasmosis.

Journal Article↗

Toxoplasmosis in a patient with non-Hodgkin's lymphoma: the need for a good differential diagnosis.

Toxoplasma gondii is an obligate intracellular parasite responsible for toxoplasmosis. Congenital and acquired forms of the disease have now been reported. In immunocompromised patients, the disease entity may resemble other diseases. Presented for discussion is an interesting case of acquired toxoplasmosis in an immunocompromised patient with several confounding factors necessitating a good differential diagnosis list. Also provided is a comprehensive review of toxoplasmosis diagnosis and management.

Journal Article↗